SCHEMBL4806963

SCHEMBL4806963

[CH2]CCCCCCCCC(C)CC

nearest known ligand 0.38

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.38
ACE2 Q9BYF1 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3838319 1.00 LMNA (0.38) LMNAACE2
SCHEMBL11324250 1.00 LMNA (0.38) LMNAACE2
SCHEMBL5076457 1.00 LMNA (0.38) LMNAACE2
SCHEMBL17219813 1.00 LMNA (0.38) LMNAACE2
SCHEMBL453968 1.00 LMNA (0.38) LMNAACE2
SCHEMBL2461382 1.00 LMNA (0.38) LMNAACE2
SCHEMBL5792782 1.00 LMNA (0.38) LMNAACE2
SCHEMBL199671 1.00 LMNA (0.38) LMNAACE2
SCHEMBL2418061 1.00 LMNA (0.38) LMNAACE2
SCHEMBL6764066 1.00 LMNA (0.38) LMNAACE2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 62 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1459626-B1 Sustained release dispenser comprising two or more sex pheromone substances and a pest control method SHINETSU CHEMICAL CO (JP) 2020-01-29 EP claimed
EP-3808792-B1 AQUEOUS EMULSION OF POLYETHER HAVING AT LEAST ONE REACTIVE SILYL GROUP KANEKA BELGIUM NV (BE) 2024-07-03 EP disclosed
CN-118201905-A Cationic lipid 武田药品工业株式会社 2024-06-14 CN disclosed
EP-4329730-A2 A SPECIFIC COMBINATION OF LIPIDS AND METHODS AND USES RELATED THERETO Helsingin Yliopisto (FI) 2024-03-06 EP disclosed
WO-2024042211-A1 A POLYETHER-BASED DISPERSANT WITH A LIGHT STABILIZING EFFECT BASF SE (DE) 2024-02-29 WO disclosed
WO-2024018762-A1 PH-SENSITIVE CATIONIC LIPID AND LIPID NANOPARTICLE 国立大学法人北海道大学 2024-01-25 WO disclosed
WO-2024018761-A1 NEUTRAL LIPID AND LIPID NANOPARTICLE 国立大学法人北海道大学 2024-01-25 WO disclosed
US-20240024252-A1 LIPID NANOPARTICLE NITTO DENKO CORPORATION (JP) 2024-01-25 US disclosed
CN-117241784-A Specific combinations of lipids and methods and uses related thereto 赫尔辛基大学 2023-12-15 CN disclosed
WO-2023188830-A1 LIPID NANOPARTICLES 国立大学法人北海道大学 2023-10-05 WO disclosed
EP-0323757-B1 Alkylaminopyrimidine derivative, process for producing the same, and insecticide, acaricide and fungicide containing the same as active ingredient UBE INDUSTRIES (JP) 1995-05-10 EP disclosed
CN-1100090-A amine derivatives of oxo-and hydroxy-substituted hydrocarbons NARHEX LTD (HK) 1995-03-15 CN disclosed
US-5385693-A Having rapid response and low phase transition temperature SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 1995-01-31 US disclosed
EP-0357372-B1 Optically active ester derivatives, preparation process thereof, liquid crystal materials and a light switching element SUMITOMO CHEMICAL CO (JP) 1994-11-17 EP disclosed
US-5264151-A Optically active ester derivatives, preparation process thereof, liquid crystal materials and a light switching element SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 1993-11-23 US disclosed
US-5124070-A High speed response SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 1992-06-23 US disclosed
US-4931455-A Alkylaminopyrimidine derivative and insecticide, acaricide and fungicide containing the same as active ingredient UBE INDUSTRIES, LTD. (JP) 1990-06-05 US disclosed
EP-0357372-A2 Optically active ester derivatives, preparation process thereof, liquid crystal materials and a light switching element SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 1990-03-07 EP disclosed
EP-0323757-A2 Alkylaminopyrimidine derivative, process for producing the same, and insecticide, acaricide and fungicide containing the same as active ingredient UBE INDUSTRIES, LTD. (JP) 1989-07-12 EP disclosed
US-4269790-A Hydrocarbylethyl sulfonyl fluoride CHEVRON RESEARCH COMPANY (US) 1981-05-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240024252-A1 LIPID NANOPARTICLE LIPC, ACOX1, ABCB4 LMNA 1094/4885ACE2 2922/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.